Item 8.01 Other Events. On January 6, 2021, Selecta Biosciences, Inc. (the "Company") issued a press release providing details of results from preclinical activities involving co-administration of AAV8 and the Company's ImmTOR technology in non-human primates. A copy of the above referenced press release is filed as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits

Exhibit
No.                                   Description

   99.1           Press Release of the Company dated January 6, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses